Related Experiment Video
Updated: May 8, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
Three novel IGSF1 mutations in four Japanese patients with X-linked congenital central hypothyroidism
Akie Nakamura1, Beata Bak, Tanya L R Silander
1MD, Department of Pediatrics, Hokkaido University School of Medicine, North 15 West 7, Kitaku, Sapporo, Japan 060-8635. akieda@med.hokudai.ac.jp.
Context:
Congenital central hypothyroidism (C-CH) is a rare disease. We investigated the molecular basis of unexplained C-CH in 4 Japanese boys.
Patients And Methods:
C-CH was diagnosed by low free T4 and/or T3 and low basal TSH concentrations. We used whole-exome sequencing of one patient with C-CH to identify potential disease-causing mutations. Thereafter, PCR direct sequencing was performed to Identify genetic defects underlying C-CH in 3 more patients. We then assessed the effects of mutations identified in the Ig superfamily, member 1 (IGSF1), gene on protein expression and membrane trafficking.
Results:
All patients had congenital hypothyroidism, and 2 had definitive prolactin deficiency. Two patients were detected by neonatal screening. The other patients were diagnosed by short stature and failure to thrive. We identified a novel nonsense variant in IGSF1 by whole-exome sequencing in patient 1, which was confirmed by PCR direct sequencing (p.R1189X). PCR direct sequencing identified the identical nonsense mutation in patient 2. Patients 3 and 4 harbored distinct missense (p.V1082E) or nonsense (p.Q645X) mutations in IGSF1. The mothers of patients 1, 3, and 4 were heterozygous for these mutations. The R1189X mutant, which lacks the transmembrane domain, failed to traffic to the plasma membrane. V1082E could be observed at the cell surface, but at greatly diminished levels relative to the wild-type form of the protein. The severely truncated Q645X mutant could not be detected by Western blot.
Conclusion:
Our findings provide additional genetic evidence that loss-of-function mutations in IGSF1 cause an X-linked form of C-CH and variable prolactin deficiency.
Insights
Genetic defects in the IGSF1 gene cause X-linked congenital central hypothyroidism (C-CH) and variable prolactin deficiency in boys. This study identified novel IGSF1 mutations in Japanese patients with unexplained C-CH.
Area of Science:
- Genetics
- Endocrinology
- Molecular Biology
Background:
- Congenital central hypothyroidism (C-CH) is a rare endocrine disorder.
- The molecular basis for many C-CH cases remains unexplained.
Purpose of the Study:
- Investigate the genetic causes of unexplained C-CH in four Japanese boys.
- Determine the functional impact of identified mutations in the IGSF1 gene.
Main Methods:
- Whole-exome sequencing and PCR direct sequencing were employed to identify genetic mutations.
- Analysis of protein expression and membrane trafficking of IGSF1 variants.
- Clinical evaluation including thyroid hormone levels and prolactin deficiency assessment.
Main Results:
- Four Japanese boys with C-CH were found to have mutations in the IGSF1 gene.
- Identified mutations include novel nonsense (p.R1189X, p.Q645X) and missense (p.V1082E) variants.
- Mutations affected IGSF1 protein expression and/or its trafficking to the plasma membrane, leading to loss-of-function.
Conclusions:
- Loss-of-function mutations in IGSF1 are a cause of X-linked C-CH.
- IGSF1 mutations are associated with variable prolactin deficiency.
- Genetic analysis of IGSF1 is crucial for diagnosing certain forms of congenital hypothyroidism.
Related Concept Videos
Hypothyroidism II: Pathophysiology
Hyperthyroidism II: Pathophysiology
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Graves' Disease I: Introduction
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life

